Taro Pharmaceutical Industries Ltd.

NYSE:TARO Stock Report

Market Cap: US$1.6b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Taro Pharmaceutical Industries Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TARO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1190.000317%
Individual Insiders7800.00208%
General Public3,027,1588.05%
Institutions5,058,76113.5%
Public Companies29,497,81378.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 90.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
78.5%
Sun Pharmaceutical Industries Limited
29,497,813US$1.3b0%no data
1.72%
Krensavage Asset Management, LLC
647,868US$27.8m0.22%12.19%
1.64%
BlackRock, Inc.
615,581US$26.5m-1.19%no data
1.52%
Renaissance Technologies LLC
571,100US$24.5m-1.43%0.04%
1.38%
Dimensional Fund Advisors LP
519,684US$22.3m-4.76%no data
0.76%
Brandes Investment Partners, LP
283,917US$12.2m-40.3%0.09%
0.7%
Eversept Partners, L.P.
263,541US$11.3m2.95%0.87%
0.61%
Qube Research & Technologies Ltd
231,004US$9.9m9,240%0.02%
0.61%
Columbia Management Investment Advisers, LLC
227,635US$9.8m-25.9%no data
0.53%
Cobas Asset Management, SGIIC, SA
200,965US$8.6m0%0.43%
0.46%
State Street Global Advisors, Inc.
172,828US$7.4m5.58%no data
0.25%
HSBC Global Asset Management (UK) Limited
95,317US$4.1m0%no data
0.25%
Geode Capital Management, LLC
93,934US$4.0m1.21%no data
0.24%
DSP BlackRock Investment Managers Pvt. Ltd.
89,475US$3.8m0%0.03%
0.21%
Millennium Management LLC
79,489US$3.4m0%no data
0.16%
Arrowstreet Capital, Limited Partnership
58,888US$2.5m48.9%no data
0.15%
Northern Trust Global Investments
54,603US$2.3m-12%no data
0.14%
Murchinson Ltd. , Asset Management Arm
54,137US$2.3m-67.7%0.29%
0.14%
The Vanguard Group, Inc.
53,729US$2.3m5.68%no data
0.13%
ARK Investment Management LLC
50,446US$2.2m-8.72%0.02%
0.12%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
45,075US$1.9m33.5%no data
0.11%
UBS Asset Management AG
42,937US$1.8m-1.05%no data
0.11%
Norges Bank Investment Management
42,835US$1.8m0%no data
0.11%
Eaton Vance Management
42,730US$1.8m10.7%no data
0.07%
Citadel Advisors LLC
26,469US$1.1m75.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/24 03:43
End of Day Share Price 2024/06/24 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Taro Pharmaceutical Industries Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Randall StanickyGoldman Sachs
Raghuram SelvarajuH.C. Wainwright & Co.
Kenneth CacciatoreTD Cowen